GRAND RAPIDS (WZZM) -- The growing list of people charged with mislabeling and reselling prescription drugs at Kentwood Pharmacy has forced a delay of trial in federal court.
A Feb. 25 jury trial for company CEO Kim Duron Mulder and 13 co-defendants was postponed due to the addition of more defendants and more criminal charges.
Two women face arraignment Monday for comingling previously dispensed drugs with supplies already in stock.
Kentwood Pharmacy employees face a battery of charges for restocking previously dispensed drugs so they could be resold.
Under the ruse, the pharmacy billed health insurance companies multiple times for the same drugs, the government alleges.
Several defendants are charged with submitting false claims to Medicaid, Medicare and private insurers. Mulder, the CEO, faces three new counts of money laundering involving deposits of $235,000.
If convicted, Mulder and two others may be on the hook for more than $60 million. That's what the government says they made from the scam.
Mulder also stands to lose an additional $283,510 in forfeiture proceedings.